A User Guide: National Statement on Ethical Conduct in Human Research (2007) - Updated 2018
This National Statement on Ethical Conduct in Human Research (‘National Statement’) is intended for use by:
• any researcher conducting research with human participants;
• any member of an ethical review body reviewing that research;
• those involved in research governance;
and
• potential research participants.
This brief guide describes the structure of the document and suggests how each of these groups might use it. Note that ‘review body’ refers both to Human Research Ethics Committees (HRECs) and to non-HREC review bodies.
The Preamble sets out the historical context of the National Statement. This is followed by a brief explanation of its purpose, scope and limits. The document then has five sections, with multiple chapters in Sections 2 to 5.
• Section 1: Values and principles of ethical conduct sets out values and principles that apply to all human research. It is essential that researchers and review bodies consider these values and principles and be satisfied that the research proposal addresses and reflects them.
• Section 2: Themes in research ethics: risk and benefit, consent discusses the concept of risk in research and the role of participants’ consent – themes in all human research – and is again essential for all users.
Chapter 2.1 will help researchers and reviewers to understand and describe
the level of risk involved in the planned research, and how to minimise, justify and manage that risk, and (with reference to Chapter 5.1) what level of ethical review is suitable.
Chapters 2.2 and 2.3 will help to identify the information that needs to be disclosed to participants. It will help researchers to draft information for
participants and plan the consent process (or develop a proposal for waiver of consent). And it will help reviewers to assess the suitability of the proposed consent process.
All of Section 2 will help participants understand what information they are entitled to receive, and what their participation in research will characteristically involve.
• Section 3: Ethical considerations in the design, development, review and
conduct of research will help researchers and reviewers to identify ethical matters specific to the research methods proposed.
• Section 4: Ethical considerations specific to participants will help researchers and reviewers to identify ethical matters relating to specific categories of research participants. Participants in these categories will also find this Section valuable.
• Section 5: Processes of research governance and ethical review will help those involved in research governance to understand their responsibilities for research ethics and ethical review and monitoring of human research, and provides criteria for their accountability. Chapter 5.2 will help researchers and reviewers to identify their responsibilities in relation to the ethical review of research.
This National Statement does not exhaust the ethical discussion of human research. Even a single research field covers a multitude of different situations about which the National Statement will not always offer specific
guidance, or to which its application may be uncertain. Where other guidelines and codes of practice in particular research fields are consistent with the National Statement, researchers and members of ethical review bodies should draw on them when necessary to clarify researchers’ ethical obligations in particular contexts.
Authors of this National Statement
This National Statement has been jointly developed by the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC) and Universities Australia (UA). This joint undertaking reflects a widely shared conviction that there is a need for ethical guidelines that are genuinely applicable to all human research and it gives expression to the shared responsibility for ethically good research described above.
Clinical Research News
다가오는 임상 시험
-
Kanuni Sultan Suleyman Training and Research Hospital아직 모집하지 않음
-
Children's National Research Institute아직 모집하지 않음수모세포종 재발성 | 뇌실막종 재발성 | 뇌종양 재발 | 고급 신경아교종 | CNS의 비정형 토라 토이드/횡격막 종양 (ATRT) | 미만성 중뇌교종 또는 미만성 내연성 교뇌교종
-
BOUCHRA BENKESSOU모병
-
Bursa City Hospital모병IgA 혈관염 | Gastrointestinal Involvement터키 (Türkiye)
-
OHSU Knight Cancer InstituteOregon Health and Science University아직 모집하지 않음
-
Far Eastern Memorial HospitalNeihu Lixin TCM Clinic모병
-
Sultan Abdulhamid Han Training and Research Hospital...아직 모집하지 않음
-
Surabaya State University아직 모집하지 않음산화 스트레스 | 운동 회복 | 운동으로 인한 근육 손상 | 스포츠 퍼포먼스 | 호기성 용량인도네시아
-
Tanta University아직 모집하지 않음TBI(외상성 뇌손상) | 급성호흡곤란증후군 | Fibrinogen Albumin Ratio이집트
-
Robert Flavell, MD, PhDFortis Therapeutics, Inc.; Kyntra Bio아직 모집하지 않음방광암 | 고급 고형 종양 | 신경초 신생물 | 고형암 | 고형 종양, 성인 | 고형암 | 방광 신생물 | 고형 종양 악성종양 | 신경초종양 | 신경초 종양 | Solid Tumor Neoplasms | Nerve Sheath Tumor, Nos미국
Clinical Research Jobs
-
Japan - Tokyo
-
Singapore - Singapore
-
United Kingdom - Edinburgh
-
Canada - Québec - MontrealCanada - Ontario - Toronto
-
United States - North Carolina - Durham
-
Romania - New York - Cluj-Napoca
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China